Results 1 to 10 of about 96,164 (192)
Journal of Education, Health and Sport, 2015 Smiyan S. I., Danchak S. V. Корекція ендотоксикозу і синдрому пероксидації у хворих на подагру в поєднанні з неалкогольним стеатогепатитом = Lipid peroxidation and endotoxemia syndrome сorrection in patients with gout combined with nonalcoholic ...
S. I. Smiyan, S. V. Danchak
doaj +3 more sources
Plasma Extracellular Vesicles Contain Protein Biomarkers for Capturing Stages of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Preliminary Exploratory Study [PDF]
BiomoleculesMetabolic dysfunction-associated steatotic liver disease (MASLD) is increasing in both prevalence and severity, highlighting the need for non-invasive biomarkers to assess disease activity.
Yakun Li +16 more
doaj +2 more sources
Necroptosis in Nonalcoholic Steatohepatitis [PDF]
Cellular and Molecular Gastroenterology and Hepatology, 2015 Jérémie Gautheron +2 more
openalex +4 more sources
P-80 SEVERELY OBESE PATIENTS HAD HEPATIC FIBROSIS EVEN WITHOUT METABOLIC SYNDROME
Annals of Hepatology, 2021 Introduction: Metabolic Associated Fatty Liver Disease (MAFLD) is a clinic-pathological condition commonly associated with metabolic syndrome (MS) and this association is frequently found in severely obese. Objective: To compare clinical and histological
Carla Daltro +4 more
doaj +1 more source
O-22 METABOLIC ASSOCIATED FATTY LIVER DISEASE: A SEVERE LIVER DISEASE
Annals of Hepatology, 2021 Background: The spectrum of metabolic associated fatty liver disease (MAFLD) includes steatosis, steatohepatitis, that can progress to cirrhosis, hepatocellular carcinoma, and to advanced stage of liver disease.
Ana Rafaela S. Do Vale +5 more
doaj +1 more source
Annals of Hepatology, 2021 Background: The prevalence of metabolic associated fatty liver disease (MAFLD) in lean patients has grown around the world and the better understanding of this liver disease, in these individuals, has become of interest.
Andreza Rosa Cabral +6 more
doaj +1 more source
Annals of Hepatology, 2021 Introduction: Metabolic associated fatty liver disease (MAFLD) is the most common cause of chronic liver disease worldwide. Recently, the relationship between MAFLD and chronic kidney disease has raised more interest because this relationship may be an ...
Kellyane Dias Carvalho +3 more
doaj +1 more source
Cells, 2021 5′AMP-activated protein kinase (AMPK) is known as metabolic sensor in mammalian cells that becomes activated by an increasing adenosine monophosphate (AMP)/adenosine triphosphate (ATP) ratio. The heterotrimeric AMPK protein comprises three subunits, each
Christian von Loeffelholz +2 more
doaj +1 more source
Iron and steatohepatitis [PDF]
Journal of Gastroenterology and Hepatology, 2012 AbstractAs the main iron storage site in the body and the main source of the iron‐regulatory hormone, hepcidin, the liver plays a pivotal role in iron homeostasis. A variable degree of hepatic iron accumulation has long been recognized in a number of chronic liver diseases.
CORRADINI, Elena, PIETRANGELO, Antonello
openaire +2 more sources
The Korean Journal of Gastroenterology, 2021 Backgrounds/Aims: Steatohepatitis related to metabolic syndrome is a chronic liver disease prevalent in patients not only with non-alcoholic steatohepatitis but also with alcoholic liver disease and chronic viral hepatitis.
Nae-Yun Heo +10 more
doaj +1 more source